Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Foxo3 Transcription Factor Drives Pathogenic T Helper 1 Differentiation by Inducing the Expression of Eomes.
Bedside to bench to bedside research: Estrogen receptor beta ligand as a candidate neuroprotective treatment for multiple sclerosis.
Mitochondrial dysfunction is an important cause of neurological deficits in an inflammatory model of multiple sclerosis.
Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy.
Multiple sclerosis: Biomarkers and genetic variants reflect disease course in multiple sclerosis.
To fingolimod and beyond: The rich pipeline of drug candidates that target S1P signaling.
Extracellular Vesicles from Vascular Endothelial Cells Promote Survival, Proliferation and Motility of Oligodendrocyte Precursor Cells.
MicroRNA-155 enhances T cell trafficking and antiviral effector function in a model of coronavirus-induced neurologic disease.
IL-27 plasma level in relapsing remitting multiple sclerosis subjects: The double-faced cytokine.
Imaging of progressive weakness or numbness of central or peripheral origin.
Autoimmunity meets genetics: Multiple sclerosis in a patient with Kallmann syndrome.
Improved Automatic Detection of New T2 Lesions in Multiple Sclerosis Using Deformation Fields.
ActiGait implantable drop foot stimulator in multiple sclerosis: a new indication.
Myelin Sheath Injury in Kaolin-Induced Hydrocephalus: A Light and Electron Microscopy Study.
Cryptococcal meningitis after fingolimod discontinuation in a patient with multiple sclerosis.
An attenuated immune response by Schwann cells and macrophages inhibits nerve regeneration in aged rats.
Acute demyelination following radiotherapy for glioma: a cautionary tale.
Myelin Oligodendrocyte Glycoprotein Antibody Persistency in a Steroid-Dependent ADEM Case.
Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study.
Neuromyelitis optica spectrum initially diagnosed as antiphospholipid antibody myelitis.
Healthy Life-Years Lost and Excess Bed-Days Due to 6 Patient Safety Incidents: Empirical Evidence From English Hospitals.
[Recurrent encephalitis following annual influenza vaccine. Case report].
Adult anaplastic pilocytic astrocytoma - a diagnostic challenge? A case series and literature review.
Factitious Graves' disease due to biotin immunoassay interference - A case and review of the literature.
EVASEP: A Noninterventional Study Describing the Perception of Neurologists, Patients, and Caregivers on Caregivers' Role in the Support of Patients Suffering from Multiple Sclerosis Treated with Subcutaneous Interferon Beta 1a.
Pages
« first
‹ previous
…
806
807
808
809
810
811
812
813
814
next ›
last »